VanEck Pharmaceutical ETF (NASDAQ:PPH) Shares Acquired by Jane Street Group LLC

Jane Street Group LLC lifted its stake in shares of VanEck Pharmaceutical ETF (NASDAQ:PPH) by 124.0% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 19,436 shares of the company’s stock after acquiring an additional 10,759 shares during the quarter. Jane Street Group LLC owned 0.26% of VanEck Pharmaceutical ETF worth $1,847,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently modified their holdings of the company. Stifel Financial Corp grew its position in VanEck Pharmaceutical ETF by 13.4% during the 3rd quarter. Stifel Financial Corp now owns 7,810 shares of the company’s stock worth $742,000 after purchasing an additional 924 shares in the last quarter. Miller Investment Management LP grew its holdings in shares of VanEck Pharmaceutical ETF by 13.4% during the third quarter. Miller Investment Management LP now owns 207,535 shares of the company’s stock valued at $19,722,000 after buying an additional 24,446 shares in the last quarter. Beck Capital Management LLC lifted its stake in VanEck Pharmaceutical ETF by 5.2% in the 3rd quarter. Beck Capital Management LLC now owns 22,383 shares of the company’s stock worth $2,127,000 after acquiring an additional 1,109 shares in the last quarter. Townsquare Capital LLC boosted its position in VanEck Pharmaceutical ETF by 3.8% during the 3rd quarter. Townsquare Capital LLC now owns 3,519 shares of the company’s stock worth $334,000 after acquiring an additional 130 shares during the period. Finally, FMR LLC grew its holdings in shares of VanEck Pharmaceutical ETF by 12.5% during the 3rd quarter. FMR LLC now owns 1,905 shares of the company’s stock valued at $181,000 after acquiring an additional 212 shares in the last quarter.

VanEck Pharmaceutical ETF Price Performance

NASDAQ PPH opened at $87.70 on Thursday. VanEck Pharmaceutical ETF has a fifty-two week low of $80.57 and a fifty-two week high of $99.51. The stock’s 50-day moving average is $89.82 and its two-hundred day moving average is $92.79. The firm has a market cap of $648.10 million, a P/E ratio of 21.04 and a beta of 0.72.

VanEck Pharmaceutical ETF Profile

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.